Cibus (CBUS) announced the transfer of gene-edited materials for herbicide tolerance in rice to its partner, Interoc. This transition facilitates the commencement by Interoc of testing and production in anticipation of the forthcoming launch of Interoc’s Cibus enhanced seed products into the Latin American agricultural sector.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBUS:
- Cibus Strengthens Board with Appointment of Thomas Urban
- Cibus: Emerging Revenue Traction and Streamlined Cost Structure Support Buy Rating and Favorable Risk‑Reward Profile
- Cibus Launches Underwritten Public Offering of Common Stock
- Cibus 6.98M share Spot Secondary priced at $2.15
- Cibus announces Class A common stock offering, no amount given